Abeona Therapeutics Inc. Reduces Loan Interest Rate and Issues Warrants in Amended Agreement
Reuters
Jul 19
<a href="https://laohu8.com/S/ABEOW">Abeona Therapeutics Inc.</a> Reduces Loan Interest Rate and Issues Warrants in Amended Agreement
Abeona Therapeutics Inc. has announced a significant amendment to its Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P., and Avenue Venture Opportunities Fund II, L.P. The amendment, effective July 18, 2025, reduces the interest rate on the company's senior secured term loan from 13.5% to a fixed rate of 11.75% per annum. As part of the agreement, Abeona issued warrants to the lenders to purchase up to 16,474 shares of the company's common stock, with an exercise price set at $6.07 per share. These warrants, which expire on July 18, 2030, can be exercised at any time before the expiration date. The agreement also includes provisions for anti-dilution adjustments and allows for cashless exercise under specific conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abeona Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-020227), on July 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.